Author： Wada K. Kamisaki Y. Nakamoto K. Itoh T.
Publisher： Elsevier
ISSN： 0014-2999
Source： European Journal of Pharmacology, Vol.296, Iss.3, 1996-02, pp. : 335-340
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Cimanga K. de Bruyne T. Hu J.P. Cos P. Apers S. Pieters L. Tona L. Kambu K. Vanden Berghe D. Vlietinck A.J.
Pharmacy and Pharmacology Communications, Vol. 5, Iss. 6, 1999-06 ,pp. :
Access to resources
Recommend
By Cimanga K. Li Y. de Bruyne T. Apers S. Cos P. Bakana P. Kambu K. Tona L. Pieters L. Vanden Berghe D. Vlietinck A.J.
Pharmacy and Pharmacology Communications, Vol. 6, Iss. 7, 2000-07 ,pp. :
By Fogliani Bruno Bouraïma-Madjebi Saliou Pineau René Cabalion Pierre
Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 40, Iss. 7, 2002-10 ,pp. :
Xanthine Oxidase Pathway and Muscle Damage. Insights from McArdle Disease
Current Pharmaceutical Design, Vol. 22, Iss. 18, 2016-05 ,pp. :